Recruiting Stroke Studies in Fontana
Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular Atherostenosis
The primary goal of the trial is to determine if the experimental arms (rivaroxaban or ticagrelor or both) are superior to the clopidogrel arm for lowering the 1-year rate of ischemic stroke, intracer...
Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial
The objective of the rFVIIa for Acute Hemorrhagic Stroke Administered at Earliest Time (FASTEST) Trial is to establish the first treatment for acute spontaneous intracerebral hemorrhage (ICH) within a...
About Stroke Clinical Trials in Fontana
A stroke occurs when blood flow to part of the brain is interrupted or reduced, depriving brain tissue of oxygen and nutrients. It is a leading cause of disability and death. Rapid treatment is critical, and prevention focuses on managing risk factors like hypertension and atrial fibrillation.
There are currently 2 stroke clinical trials recruiting participants in Fontana, CALIFORNIA. These studies are seeking a combined 2,543 participants. Research is being sponsored by University of Florida, Joseph Broderick, MD. Clinical trial participation is free and participants receive study-related medical care at no cost.
Stroke Clinical Trials in Fontana — FAQ
Are there stroke clinical trials in Fontana?
Yes, there are 2 stroke clinical trials currently recruiting in Fontana, CALIFORNIA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Fontana?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Fontana research site will contact you about next steps.
Are clinical trials in Fontana free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Fontana studies also compensate for your time and travel.
What stroke treatments are being tested?
The 2 active trials in Fontana are testing new therapies including novel drugs, biologics, and treatment approaches for stroke.
Data updated March 2, 2026 from ClinicalTrials.gov